(Q35140808)

6 August 2017

title

Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation (English)

1 reference

6 August 2017

0 references

1 reference

1 reference

systemic inflammation

1 reference

2

Khurram Nasir

1 reference

6 August 2017

5

Roger S Blumenthal

1 reference

6 August 2017

1

Chiadi E Ndumele

1 reference

6 August 2017

Raquel D Conceiçao

3

1 reference

6 August 2017

Jose A M Carvalho

series ordinal

4

1 reference

6 August 2017

Raul D Santos

series ordinal

6

1 reference

6 August 2017

language of work or name

English

0 references

publication date

5 May 2011

1 reference

Arteriosclerosis, Thrombosis, and Vascular Biology

6 August 2017

published in

1 reference

6 August 2017

volume

31

1 reference

6 August 2017

issue

8

1 reference

6 August 2017

page(s)

1927-1932

1 reference

Fatty liver: a novel component of the metabolic syndrome

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

Molecular mediators of hepatic steatosis and liver injury

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

Nonalcoholic fatty liver disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

Novel clinical markers of vascular wall inflammation

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

Test validity of periodic liver function tests in a population of Japanese male bank employees

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

Atherosclerosis — An Inflammatory Disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

Hepatic steatosis is associated with a greater prevalence of coronary artery calcification in asymptomatic men.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

The utility of radiological imaging in nonalcoholic fatty liver disease.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

C-reactive protein and myocardial infarction

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148106

Prevalence of and risk factors for hepatic steatosis in Northern Italy

16 November 2018

1 reference

12 December 2020

Human blood pressure determination by sphygmomanometry

1 reference

12 December 2020

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

1 reference

12 December 2020

Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease

1 reference

12 December 2020

NASH predicts plasma inflammatory biomarkers independently of visceral fat in men

1 reference

12 December 2020

10.1161/ATVBAHA.111.228262

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference